Copyright
©2013 Baishideng.
World J Radiol. Mar 28, 2013; 5(3): 126-142
Published online Mar 28, 2013. doi: 10.4329/wjr.v5.i3.126
Published online Mar 28, 2013. doi: 10.4329/wjr.v5.i3.126
Figure 3 The fluorodeoxyglucose activity of lymphoma can be variable.
A: A positron emission tomography (PET) image of a 62-year-old male with untreated grade 2 follicular lymphoma showed strong fluorodeoxyglucose (FDG) avid lymph nodes above and below the diaphragm; B, C: A whole body PET image of a 65-year-old male with untreated chronic lymphocytic leukemia or small lymphocytic leukemia showed no FDG uptake (B) but a PET/computed tomography fusion image demonstrated retroperitoneal lymphadenopathy (C).
- Citation: Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 2013; 5(3): 126-142
- URL: https://www.wjgnet.com/1949-8470/full/v5/i3/126.htm
- DOI: https://dx.doi.org/10.4329/wjr.v5.i3.126